USCA RIA’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.78M Buy
13,069
+555
+4% +$117K 0.17% 175
2021
Q1
$2.56M Buy
12,514
+10,988
+720% +$2.16M 0.17% 175
2020
Q4
$278K Sell
1,526
-15
-1% -$2.55K 0.02% 416
2020
Q3
$258K Hold
1,541
0.02% 388
2020
Q2
$250K Sell
1,541
-91
-6% -$16.3K 0.02% 376
2020
Q1
$282K Buy
1,632
+78
+5% +$15.5K 0.03% 333
2019
Q4
$312K Buy
1,554
+13
+0.8% +$2.67K 0.03% 387
2019
Q3
$326K Sell
1,541
-95
-6% -$19.9K 0.03% 363
2019
Q2
$318K Hold
1,636
0.03% 358
2019
Q1
$269K Sell
1,636
-54
-3% -$9.55K 0.03% 362
2018
Q4
$318K Sell
1,690
-10
-0.6% -$1.85K 0.04% 329
2018
Q3
$289K Buy
1,700
+105
+7% +$17.7K 0.03% 389
2018
Q2
$261K Hold
1,595
0.03% 393
2018
Q1
$258K Hold
1,595
0.03% 388
2017
Q4
$233K Sell
1,595
-13,457
-89% -$1.92M 0.03% 391
2017
Q3
$1.89M Hold
15,052
0.24% 127
2017
Q2
$1.89M Buy
15,052
+13,357
+788% +$1.6M 0.24% 128
2017
Q1
$201K Buy
+1,695
New +$204K 0.03% 380

Other funds holding CME

USCA RIA's CME Position: Q2 2021 in Review

USCA RIA increased its CME Group (CME) stake by 4.4% in Q2 2021, buying an estimated $117K and bringing the position to 13,069 shares worth $2.78M. The position accounts for 0.17% of the portfolio, ranked #175.

USCA RIA first reported a position in CME in Q1 2017 and has held it in 18 quarters since. 1,086 funds tracked by Wall St. Rank hold CME as of Q2 2021.

  • USCA RIA held 13,069 shares of CME Group worth $2.78M as of Q2 2021.
  • USCA RIA bought 555 CME Group shares in Q2 2021, an estimated $117K.
  • CME Group made up 0.17% of USCA RIA's portfolio in Q2 2021, its #175 holding.
  • USCA RIA first reported a position in CME Group in Q1 2017 and has held it in 18 quarters since.
  • 1,086 funds tracked by Wall St. Rank held CME Group as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.